GB1305502A - - Google Patents

Info

Publication number
GB1305502A
GB1305502A GB1252771A GB1252771A GB1305502A GB 1305502 A GB1305502 A GB 1305502A GB 1252771 A GB1252771 A GB 1252771A GB 1252771 A GB1252771 A GB 1252771A GB 1305502 A GB1305502 A GB 1305502A
Authority
GB
United Kingdom
Prior art keywords
alkyl
hydrogen
formula
aldehyde
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1252771A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1305502A publication Critical patent/GB1305502A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB1252771A 1970-12-16 1971-04-30 Expired GB1305502A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9886070A 1970-12-16 1970-12-16

Publications (1)

Publication Number Publication Date
GB1305502A true GB1305502A (enExample) 1973-02-07

Family

ID=22271290

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1252771A Expired GB1305502A (enExample) 1970-12-16 1971-04-30

Country Status (2)

Country Link
US (1) US3729564A (enExample)
GB (1) GB1305502A (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033748A (en) 1976-07-02 1977-07-05 Merck & Co., Inc. Dibicyclo[3.1.1] and [2.2.1] heptyl and dibicyclo [3.1.1] and [2.2.1] heptenyl polyamines having a piperidine moiety
US4049559A (en) 1975-10-09 1977-09-20 Merck & Co., Inc. Composition for secondary and tertiary oil recovery
US4100193A (en) * 1976-06-10 1978-07-11 Merck & Co., Inc. Novel dibicyclo [2.2.2] octyl and dibicyclo [2.2.2] octenyl polyamines and methods for their preparation
GB2153831A (en) * 1984-01-14 1985-08-29 Claude Hepburn The use of cationic surfactants as crosslinking agents
WO1994025426A1 (en) * 1993-04-28 1994-11-10 Alcon Laboratories, Inc. Diamines as antimicrobial agents and use thereof in ophthalmic composition

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049417A (en) * 1975-04-28 1977-09-20 Merck & Co., Inc. Alicyclic alkylene polyamine microorganism and algae growth inhibitors
DE602004020665D1 (de) * 2003-12-09 2009-05-28 Alcon Inc Verwendung von bisaminen zur verstärkung der antimn
DE21212055T1 (de) 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
CA2953341C (en) 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
HUE067372T2 (hu) 2015-06-29 2024-10-28 Acuitas Therapeutics Inc Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
US12678515B2 (en) 2015-12-30 2026-07-14 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
US12491261B2 (en) 2016-10-26 2025-12-09 Acuitas Therapeutics, Inc. Lipid nanoparticle formulations
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
US11820728B2 (en) 2017-04-28 2023-11-21 Acuitas Therapeutics, Inc. Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP7355731B2 (ja) 2017-08-16 2023-10-03 アクイタス セラピューティクス インコーポレイテッド 脂質ナノ粒子製剤における使用のための脂質
WO2019036028A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
JP7461872B2 (ja) 2017-08-17 2024-04-04 アクイタス セラピューティクス インコーポレイテッド 脂質ナノ粒子製剤における使用のための脂質
CN111491914B (zh) * 2017-12-20 2024-04-26 罗地亚经营管理公司 新的阳离子季铵化合物和包含其的组合物及其制造方法
EP3852911B1 (en) 2018-09-21 2025-01-22 Acuitas Therapeutics, Inc. Systems and methods for manufacturing lipid nanoparticles and liposomes
CA3116576A1 (en) 2018-10-18 2020-04-23 Acuitas Therapeutics, Inc. Lipids for lipid nanoparticle delivery of active agents
PL3908568T3 (pl) 2019-01-11 2024-12-02 Acuitas Therapeutics, Inc. Lipidy do dostarczania środków czynnych w nanocząstkach lipidowych
KR20230051172A (ko) 2020-07-16 2023-04-17 아퀴타스 테라퓨틱스 인크. 지질 나노 입자에 사용하기 위한 양이온성 지질
WO2023114943A2 (en) 2021-12-16 2023-06-22 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049559A (en) 1975-10-09 1977-09-20 Merck & Co., Inc. Composition for secondary and tertiary oil recovery
US4100193A (en) * 1976-06-10 1978-07-11 Merck & Co., Inc. Novel dibicyclo [2.2.2] octyl and dibicyclo [2.2.2] octenyl polyamines and methods for their preparation
US4033748A (en) 1976-07-02 1977-07-05 Merck & Co., Inc. Dibicyclo[3.1.1] and [2.2.1] heptyl and dibicyclo [3.1.1] and [2.2.1] heptenyl polyamines having a piperidine moiety
GB2153831A (en) * 1984-01-14 1985-08-29 Claude Hepburn The use of cationic surfactants as crosslinking agents
WO1994025426A1 (en) * 1993-04-28 1994-11-10 Alcon Laboratories, Inc. Diamines as antimicrobial agents and use thereof in ophthalmic composition
US5900213A (en) * 1993-04-28 1999-05-04 Alcon Laboratories, Inc. Use of diamines to disinfect and clean contact lenses and preserve ophthalmic compositions

Also Published As

Publication number Publication date
US3729564A (en) 1973-04-24

Similar Documents

Publication Publication Date Title
ES403503A1 (es) Procedimiento para la preparación de derivados de piperidina y su utilizacion como estabilizadores
ES8304117A1 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
GB1395802A (en) Substituted benzamides and herbicidal uses thereof
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
GB1059995A (en) Preparation of alkyl 3-chloro-3-arylimino-propionates and tautomers thereof
ES409192A1 (es) Procedimiento para la preparacion de derivados del acido amino-citrico.
GB1343163A (en) Cyclopropane carboxylates processes for producing them and compo sitions containing them
GB1208195A (en) Process for producing benzodiazepine derivatives
GB1329680A (en) Process for the preparation of carbanilic acid propargyl esters
GB1359171A (en) Azo dye-stuffs their manufacture and use
ES393107A1 (es) Procedimiento para la preparacion de cianuros de diazonio.
ES419739A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas (2) sustituidas.
ES303109A1 (es) Procedimiento para la preparacion de imidazo quinazolinas y pirimido quinazolinas.
GB1193347A (en) Production of Alkylenealdehyde-Substituted Hexahydropyrimidin-2-Ones and -Thiones
GB1454529A (en) Thiophene derivatives
GB1197138A (en) Method for Producing Benzodiazephine Derivatives
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.
ES419656A1 (es) Un procedimiento para la produccion de un compuesto de un ester alilaminoalcanolico.
ES387817A1 (es) Procedimiento de obtencion de composiciones insecticidas y fungicidas a base de esteres organicos del acido fosfori- co.
ES393339A1 (es) Un procedimiento para la preparacion de derivados de nafto-quinona.
GB1499193A (en) Indolino-spiropyran compounds useful as colour formers
ES417729A1 (es) Procedimiento para la preparacion de nuevos aminoetanoles.
ES356224A1 (es) Procedimiento para la produccion de diariletilaminas.
ES310939A1 (es) Procedimiento para la preparacion de nuevos compuestos n-heterociclicos.
ES323103A1 (es) Un procedimiento para la preparación de nuevas penicilinas.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee